Clinical Characteristics of Lung Cancer in China
NCT05423236 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 119785
Last updated 2022-06-21
Summary
This study is a single-center, real-world and large-population-based retrospective study. In the current study, the investigators not only describe the changes of demographic and basic clinicopathological characteristics of lung cancer during recent years but delineate the correlation between clinicopathological features and common clinical blood tests in such a large population.
Conditions
Sponsors & Collaborators
-
Shanghai Pulmonary Hospital, Shanghai, China
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2023-06-30
- Completion
- 2023-06-30
Countries
- China
Study Locations
More Related Trials
-
Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China
NCT01928836 ·Status: COMPLETED
-
Survival Outcomes of Lung Cancer
NCT03647098 ·Status: RECRUITING
-
Preoperative and Postoperative ctDNA Comparison in Early Stage Lung Cancer
NCT03805256 ·Status: UNKNOWN
-
Are Doctors Familiar With the Test Characteristics of Lung Cancer Screening?
NCT02542332 ·Status: COMPLETED ·Phase: NA
-
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer
NCT05979623 ·Status: COMPLETED
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer
NCT02726633 ·Status: UNKNOWN
-
A Prognosis and Predicting Genetic Study of Lung Cancer
NCT03234179 ·Status: NOT_YET_RECRUITING
-
A Preliminary Study on the Detection of Plasma Markers in Early Diagnosis for Lung Cancer
NCT04558255 ·Status: UNKNOWN
-
Multiomics Tumor Evolution Model of NSCLC
NCT05352035 ·Status: RECRUITING
-
the Quality of Life Assessment of Lung Cancer Patients in China
NCT01914120 ·Status: UNKNOWN
-
A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
NCT05337163 ·Status: COMPLETED
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
A Study to Evaluate Clinical Characteristics of Lung Cancer in Patients With Surgeries and Adjuvant Therapies
NCT03421093 ·Status: COMPLETED
-
Circulating Immune Markers for Prognostic Evaluation in Postoperative Lung Cancer Patients
NCT07242482 ·Status: NOT_YET_RECRUITING
-
Early Cancer Detection Test - Lung Cancer China
NCT04216511 ·Status: UNKNOWN
-
Development of a Biologic Specimen Bank for the Study of Early Markers of Lung Cancer Among Tin Miners in Yunnan, China
NCT00340405 ·Status: COMPLETED
-
Multiplex Analysis of Circulating Tumor DNA
NCT03301961 ·Status: UNKNOWN
-
Cancer Genome Atlas of China:Lung Cancer
NCT04266483 ·Status: UNKNOWN
-
Lung Cancer Risk Assessment and Etiology
NCT06328621 ·Status: COMPLETED
-
Evolution of Multiple Primary Lung Cancer (Evolution)
NCT04326751 ·Status: UNKNOWN
-
The Role of Microbiota on the Development of Lung Cancer
NCT03454685 ·Status: UNKNOWN
-
Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
NCT06699979 ·Status: RECRUITING
-
To Evaluate the Correlation Between the Results of Specific Gene Testing and the Efficacy of Targeted Therapy in Patients With NSCLC
NCT05805267 ·Status: COMPLETED
-
Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
NCT06255197 ·Status: RECRUITING